WTC Health Program Coverage & Ground Zero Toxin Exposure Explorer

25 Years Post-9/11 Medical & Epidemiological Review (2001–2026)
Documented Dementia Cases
1,240+
Diagnosed responders (Stony Brook / Mount Sinai cohorts)
Monitored Responder Cohort
54,000
Enrolled general responders & recovery workers
WTCHP Dementia Coverage
Not Covered
Exempt from federal direct medical compensation
Epidemiological Petition Progress
75%
3 of 4 NIOSH evidentiary criteria met
WTC Health Program Condition Coverage Matrix
Click condition to audit

Under the James Zadroga 9/11 Health & Compensation Act, only listed conditions receive 100% paid care and monitoring. Select a condition to assess coverage and research status:

Early-Onset Dementia & Cognitive Impairment

Mount Sinai and Stony Brook longitudinal studies indicate cognitive impairment rates 2.5x to 3.5x higher in high-exposure responders than age-matched general public. Currently omitted from WTCHP covered list.

25-Year Ground Zero Neurotoxin Timeline
Year 2026 (25-Yr Latency)

Particulate matter (PM2.5), pulverized cement, benzene, asbestos, and polycyclic aromatic hydrocarbons (PAHs) crossed blood-brain and alveolar barriers:

2026: 25-Year Latency & Neurodegenerative Climax

Over 1,240 responders manifest clinically validated dementia and early Alzheimer’s-like pathology. Autopsies confirm neuroinflammation, amyloid accumulation, and blood-brain barrier vascular disruptions directly correlated with dense dust cloud exposure.

Identified Ground Zero Chemical Agents:
Fine Particulate (PM2.5) Benzene & VOCs Heavy Metals (Lead, Mercury) Dioxins & Furans Pulverized Silica Dust
NIOSH Petition Evaluation Checklist

Generated Policy Brief & Epidemiological Summary

Live synthesis ready for advocacy, clinical review, or legislative action.

Enjoy this tool? Build your own with Super